Jyh-Cherng Yu

2.8k total citations
20 papers, 554 citations indexed

About

Jyh-Cherng Yu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jyh-Cherng Yu has authored 20 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Jyh-Cherng Yu's work include Bone health and treatments (5 papers), Breast Cancer Treatment Studies (5 papers) and Breast Lesions and Carcinomas (4 papers). Jyh-Cherng Yu is often cited by papers focused on Bone health and treatments (5 papers), Breast Cancer Treatment Studies (5 papers) and Breast Lesions and Carcinomas (4 papers). Jyh-Cherng Yu collaborates with scholars based in Taiwan, United States and China. Jyh-Cherng Yu's co-authors include Chen‐Yang Shen, Tsu-Yi Chao, Chih‐Hung Ku, Pei-Ei Wu, Shou-Tung Chen, Yi-Ping Fu, Da‐Tian Bau, Cheng‐Ping Yu, Anthony J. Janckila and Lung T. Yam and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Jyh-Cherng Yu

19 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jyh-Cherng Yu Taiwan 13 295 176 147 109 80 20 554
Ramon Mohanlal United States 11 157 0.5× 37 0.2× 226 1.5× 69 0.6× 43 0.5× 49 539
Ke Gu China 13 150 0.5× 76 0.4× 91 0.6× 61 0.6× 61 0.8× 48 471
Min Kong China 13 313 1.1× 185 1.1× 68 0.5× 191 1.8× 26 0.3× 54 590
Qinghong Qin China 15 224 0.8× 223 1.3× 156 1.1× 123 1.1× 76 0.9× 25 560
Linhai Zhu China 14 272 0.9× 98 0.6× 183 1.2× 95 0.9× 22 0.3× 55 605
Zhongyu Wang China 12 286 1.0× 247 1.4× 180 1.2× 97 0.9× 34 0.4× 19 594
Bertram Illert Germany 13 286 1.0× 141 0.8× 154 1.0× 74 0.7× 32 0.4× 30 645
Katsunori Tauchi Japan 11 127 0.4× 56 0.3× 118 0.8× 114 1.0× 30 0.4× 47 406
Zhihong Xiao China 10 95 0.3× 67 0.4× 194 1.3× 98 0.9× 44 0.6× 40 469

Countries citing papers authored by Jyh-Cherng Yu

Since Specialization
Citations

This map shows the geographic impact of Jyh-Cherng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jyh-Cherng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jyh-Cherng Yu more than expected).

Fields of papers citing papers by Jyh-Cherng Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jyh-Cherng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jyh-Cherng Yu. The network helps show where Jyh-Cherng Yu may publish in the future.

Co-authorship network of co-authors of Jyh-Cherng Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jyh-Cherng Yu. A scholar is included among the top collaborators of Jyh-Cherng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jyh-Cherng Yu. Jyh-Cherng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Jyh-Cherng, et al.. (2025). The predict value of lymph node status pre-operation by ultrasound, mammography and MRI in early breast cancer. Journal of the Formosan Medical Association.
2.
Chu, Chi‐Ming, Yu‐Jia Chang, Jyh-Cherng Yu, et al.. (2019). Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis. Scientific Reports. 9(1). 4484–4484. 32 indexed citations
3.
Yang, Shi‐Yi, Chia-Ni Hsiung, Yao-Jen Li, et al.. (2016). Fanconi anemia genes in lung adenocarcinoma- a pathway-wide study on cancer susceptibility. Journal of Biomedical Science. 23(1). 23–23. 17 indexed citations
4.
Chang, Chia-Wei, Jyh-Cherng Yu, Yi‐Hsien Hsieh, et al.. (2016). MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer. Oncotarget. 7(13). 16462–16478. 48 indexed citations
5.
Hsu, Ren‐Jun, Jyh-Cherng Yu, Fung-Wei Chang, et al.. (2015). The triterpenoids of Hibiscus syriacus induce apoptosis and inhibit cell migration in breast cancer cells. BMC Complementary and Alternative Medicine. 15(1). 65–65. 52 indexed citations
6.
Chou, Wen‐Cheng, et al.. (2015). The Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug Sensitivity. PLoS ONE. 10(6). e0128472–e0128472. 41 indexed citations
7.
Janckila, Anthony J., et al.. (2015). Association of Tartrate-Resistant Acid Phosphatase-Expressed Macrophages and Metastatic Breast Cancer Progression. Medicine. 94(48). e2165–e2165. 6 indexed citations
8.
Yu, Jyh-Cherng, et al.. (2015). Oncological Safety and Outcomes of Nipple-Sparing Mastectomy With Breast Reconstruction. Annals of Plastic Surgery. 74(Supplement 2). S127–S131. 15 indexed citations
9.
Liao, Guo‐Shiou, Hao‐Ming Chang, Ming‐Lang Shih, et al.. (2014). Successful nonsurgical treatment for synchronous acute cholecystitis and acute appendicitis: A case report and review of the literatures. Journal of Medical Sciences. 34(3). 121–121. 9 indexed citations
10.
Wu, Yi‐Ying, Anthony J. Janckila, Chih‐Hung Ku, et al.. (2010). Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis. BMC Cancer. 10(1). 158–158. 25 indexed citations
11.
Hsu, Hsian-He, Jyh-Cherng Yu, Wei-Chou Chang, et al.. (2009). Ultrasonographic alterations associated with the dilatation of mammary ducts: feature analysis and BI-RADS assessment. European Radiology. 20(2). 293–302. 21 indexed citations
12.
Tsai, Shih‐Hung, Chih‐Hung Ku, Anthony J. Janckila, et al.. (2007). The Semiquantitative Bone Scintigraphy Index Correlates With Serum Tartrate-Resistant Acid Phosphatase Activity in Breast Cancer Patients With Bone Metastasis. Mayo Clinic Proceedings. 82(8). 917–926. 12 indexed citations
13.
Chu, Heng-Cheng, Huan‐Fa Hsieh, Jong-Shiaw Jin, et al.. (2006). Xanthogranulomatous Panniculitis After Spillage of Gallstones During Laparoscopic Cholecystectomy Mimics Intra-abdominal Malignancy. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 16(4). 248–250. 6 indexed citations
14.
Ku, Chih‐Hung, et al.. (2006). Application of Intraoperative Ultrasound to Nonsentinel Node Assessment in Primary Breast Cancer. Clinical Cancer Research. 12(12). 3746–3753. 4 indexed citations
15.
16.
Ku, Chih‐Hung, et al.. (2006). Tartrate-Resistant Acid Phosphatase 5b Activity Is a Useful Bone Marker for Monitoring Bone Metastases in Breast Cancer Patients after Treatment. Cancer Epidemiology Biomarkers & Prevention. 15(3). 424–428. 31 indexed citations
17.
Chao, Tsu-Yi, et al.. (2005). Tartrate-Resistant Acid Phosphatase 5b is a Useful Serum Marker for Extensive Bone Metastasis in Breast Cancer Patients. Clinical Cancer Research. 11(2). 544–550. 47 indexed citations
18.
Shyu, Rong‐Yaun, et al.. (2004). Establishment and Characterization of a Human Gastric Carcinoma Cell Line TMC-1. Cells Tissues Organs. 177(1). 37–46. 3 indexed citations
19.
Bau, Da‐Tian, Yi-Ping Fu, Shou-Tung Chen, et al.. (2004). Breast Cancer Risk and the DNA Double-Strand Break End-Joining Capacity of Nonhomologous End-Joining Genes Are Affected by BRCA1 . Cancer Research. 64(14). 5013–5019. 114 indexed citations
20.
Wu, Ching-Tang, Jyh-Cherng Yu, Chun‐Chang Yeh, et al.. (1999). Preincisional Dextromethorphan Treatment Decreases Postoperative Pain and Opioid Requirement After Laparoscopic Cholecystectomy. Anesthesia & Analgesia. 88(6). 1331–1334. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026